RxAll Inc.

RxAll Inc.
	File:RxAll Inc. photo, 2019..jpg
Type	Private
ISIN	🆔
Industry	Medical Technology
Founded 📆	January 1, 2016.
Founder 👔
Headquarters 🏙️	165 Whitney Avenue, New Haven, Connecticut 06520, United States.
Area served 🗺️	Worldwide
Key people	Adebayo Alonge; (Co-founder / CEO); Ankur Kapadia; (President); Amy Kao; (Co-founder / CMO); Mads Glahder; (Chief data scientist); Wei Liu; (Co-founder / CTO)
Products 📟	Medical Devices
Total equity	$1,305,137
Members
Number of employees
🌐 Website	https://www.rxall.net/about-us
📇 Address
📞 telephone
	;

RxAll Inc. is an Health information technology/Big data Startup company. The company labor with drug regulatory agencies and other stakeholders^[1]to lessen branded fake medicines and make sure that patients receive high quality verified drugs, and help pharma manufacturers^{[disambiguation needed]} gain more sales, and patients have better access to high quality drugs.

Founding History

RxAll Inc. was established on January 1, 2016 by Adebayo Alonge, Amy Kao and Wei Liu. They were graduate students of Yale University - Yale School of Management at the time.^[2] It is seen as an important weapon against illegal pharmaceutical outfits in Kenya. ^[3] Alonge's father was nearly killed by fake salbutamol tablets in Nigeria in 2005. ^[4]

Early Challenges

Like many start-ups, RxAll Inc. came up against early challenges when it ran out of cash in the first quarter of 2017, which lead to the resignation of more than three-quarters of the staff, and nearly led to the collapse of the company at this early stage. However, Chief executive official, Adebayo Alonge managed to raise about $400,000 in grants and bootstrapped funds from the Nigerian government, the Yale start-up ecosystem, Merck{{dn|date=February 2020]}, Villgro and other support networks.

Products

The company's products are:

RxScanner

RxScanner is an handheld drug authenticator device created for patients to verify their drugs and help drug regulators to reduce administrative burden, improve record keeping and also improved productivity and successful prosecution of bad actors.^[5] The devise is in use by U.S food and drug administration, Hospitals, Pharmacies and Big Pharma across the world.^[6]

RxAll POS

RxAll POS is a Point of sale simple device created for Pharmacies in growth market that^[7]enables complete automation of the pharmacy management system.

Growth and Expansion

In the space of two years, RxAll Inc. achieved a multi-million dollar valuation and ramped up seven-figure sales orders in its first year.^[8] Through the effort of its CEO, the company gained market entry into East Africa (Kenya and Uganda), West Africa (Nigeria and Ghana), Southeast Asia (Myanmar, Malaysia and Singapore), and the Americas (Canada, United States and Columbia).^[9]

Investors

Some of the company's investors are:

HAX (HAX Accelerator)
SOSV ( The accelerator VC)
Brinc
Hello Tomorrow
Innovate Yale.^[10]

Award

RxAll Inc. won the 2019 BNP Paribas group deep tech award otherwise known as Hello Tomorrow, a competition crafted for tech innovators and entrepreneurs, worth €100,000.^[11]

Also, the company was the recipient of 2018 CIO Review Most Promising PharmaTech Vendor Award and 2018 Katapult FutureFest’s Glstart-up award in Oslo, Norway.

External Links

References

↑ "RxAll Inc. Making giant stride". How we made it in Africa. 2017-10-19. Unknown parameter |url-status= ignored (help)
↑ RxAll (2018-07-23). "RxAll Inc. signs MOU with CTI Africa". Medium. Retrieved 2020-01-26.
↑ "How Advances in Tech Are Battling the Fake Meds Epidemic (In Kenya)". Nairobi Wire. 24 January 2020. Retrieved 8 February 2020.
↑ "Fighting fake medicines". Chemistry World. 16 May 2019. Retrieved 8 February 2020.
↑ "RxAll, Founded by Adebayo Alonge '16, Named Best Early-Stage Startup in Hello Tomorrow Global Challenge". Yale School of Management. 2019-03-21. Retrieved 2020-01-26.
↑ "RxAll Inc". F6S. Retrieved 2020-01-26.
↑ Leadership, Insurance Thought. "RxAll Inc". Innovator's Edge. Retrieved 2020-01-26.
↑ "RxAll Inc. moving ahead". CrunchBase. Unknown parameter |url-status= ignored (help)
↑ "Fight the fakes: how to beat the $200bn medicine counterfeiters". Guardian. 5 June 2019. Retrieved 11 February 2020.
↑ "RxAll Inc. making terrific progress". Angel. Unknown parameter |url-status= ignored (help)
↑ "For His Anti-Fake Drugs Startup, Nigerian Pharmacist Bayo Alonge Beats 4,500 From 119 Countries To Win €100,000 Prize". Sahara Reporters. 21 March 2019. Retrieved 11 February 2020.

This article "RxAll Inc." is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:RxAll Inc.. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

This page exists already on Wikipedia.

[1] "RxAll Inc. Making giant stride". How we made it in Africa. 2017-10-19. Unknown parameter |url-status= ignored (help)

[2] RxAll (2018-07-23). "RxAll Inc. signs MOU with CTI Africa". Medium. Retrieved 2020-01-26.

[3] "How Advances in Tech Are Battling the Fake Meds Epidemic (In Kenya)". Nairobi Wire. 24 January 2020. Retrieved 8 February 2020.

[4] "Fighting fake medicines". Chemistry World. 16 May 2019. Retrieved 8 February 2020.

[5] "RxAll, Founded by Adebayo Alonge '16, Named Best Early-Stage Startup in Hello Tomorrow Global Challenge". Yale School of Management. 2019-03-21. Retrieved 2020-01-26.

[6] "RxAll Inc". F6S. Retrieved 2020-01-26.

[7] Leadership, Insurance Thought. "RxAll Inc". Innovator's Edge. Retrieved 2020-01-26.

[8] "RxAll Inc. moving ahead". CrunchBase. Unknown parameter |url-status= ignored (help)

[9] "Fight the fakes: how to beat the $200bn medicine counterfeiters". Guardian. 5 June 2019. Retrieved 11 February 2020.

[10] "RxAll Inc. making terrific progress". Angel. Unknown parameter |url-status= ignored (help)

[11] "For His Anti-Fake Drugs Startup, Nigerian Pharmacist Bayo Alonge Beats 4,500 From 119 Countries To Win €100,000 Prize". Sahara Reporters. 21 March 2019. Retrieved 11 February 2020.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]